Ifosfamide

CHEMBL1024 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
261.1 g/mol
LogP
0.9
Phase
4

This alkylating chemotherapy agent works by cross-linking DNA strands within cancer cells, preventing them from replicating. It is used to treat a variety of cancers including sarcomas, testicular cancer, and lymphomas. A key concern is ifosfamide-induced hemorrhagic cystitis (bladder irritation), which is prevented by co-administering the protective agent mesna.

Peso molecular

261,0800 g/mol

LogP

0,90

TPSA

41,60 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=P1(NCCCl)OCCCN1CCCl

InChI

InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)

Molecular Formula

C7H15Cl2N2O2P

HBD / HBA

1 / 4

Enlaces Rotables

5

Átomos Pesados

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This alkylating chemotherapy agent works by cross-linking DNA strands within cancer cells, preventing them from replicating. It is used to treat a variety of cancers including sarcomas, testicular cancer, and lymphomas. A key concern is ifosfamide-induced hemorrhagic cystitis (bladder irritation), which is prevented by co-administering the protective agent mesna.

Yes, Ifosfamide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1024. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3690. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.